Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Sarepta Therapeutics (SRPT) Q2 2024 Earnings Call Transcript

TheMotleyFool

0 0

Image source: The Motley Fool.

Sarepta Therapeutics (NASDAQ: SRPT)
Q2 2024 Earnings Call
Aug 07, 2024, 4:30 p.m. ET

Operator

Source Fool.com

Sarepta Therapeutics Stock

A loss of -2.270% shows a downward development for Sarepta Therapeutics.
The community is currently still undecided about Sarepta Therapeutics with 1 Buy predictions and 0 Sell predictions.
With a target price of 130 € there is a slightly positive potential of 14.79% for Sarepta Therapeutics compared to the current price of 113.25 €.

Like: 0

SRPT

Share